Fundação Pró Rim
Quick facts
Marketed products
- Everolimus+Tacrolimus+Prednisone · Immunology / Transplantation
This triple immunosuppressive regimen inhibits T-cell proliferation and activation to prevent organ rejection after transplantation. - Mycophenolate+Tacrolimus+Prednisone · Immunology / Transplantation
This triple immunosuppressive regimen suppresses T-cell proliferation and activation to prevent organ rejection after transplantation.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: